Travel-screening documentation to enable the "Identify-Isolate-Inform" framework for emerging infectious diseases: It's all in the details

Infect Control Hosp Epidemiol. 2020 Dec;41(12):1449-1451. doi: 10.1017/ice.2020.338. Epub 2020 Aug 27.

Abstract

The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Communicable Disease Control* / methods
  • Communicable Disease Control* / organization & administration
  • Communicable Diseases, Emerging* / epidemiology
  • Communicable Diseases, Emerging* / prevention & control
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Decision Support Techniques
  • Guideline Adherence / statistics & numerical data
  • Humans
  • Mass Screening / methods*
  • Massachusetts / epidemiology
  • Records
  • Risk Assessment / methods
  • SARS-CoV-2
  • Travel / trends
  • Travel Medicine* / methods
  • Travel Medicine* / trends
  • Travel-Related Illness